<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32678235</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jul</Month><Day>16</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Proteomics analysis of FUS mutant human motoneurons reveals altered regulation of cytoskeleton and other ALS-linked proteins via 3'UTR binding.</ArticleTitle><Pagination><StartPage>11827</StartPage><MedlinePgn>11827</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">11827</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-68794-6</ELocationID><Abstract><AbstractText>Increasing evidence suggests that in Amyotrophic Lateral Sclerosis (ALS) mutated RNA binding proteins acquire aberrant functions, leading to altered RNA metabolism with significant impact on encoded protein levels. Here, by taking advantage of a human induced pluripotent stem cell-based model, we aimed to gain insights on the impact of ALS mutant FUS on the motoneuron proteome. Label-free proteomics analysis by mass-spectrometry revealed upregulation of proteins involved in catabolic processes and oxidation-reduction, and downregulation of cytoskeletal proteins and factors directing neuron projection. Mechanistically, proteome alteration does not correlate with transcriptome changes. Rather, we observed a strong correlation with selective binding of mutant FUS to target mRNAs in their 3'UTR. Novel validated targets, selectively bound by mutant FUS, include genes previously involved in familial or sporadic ALS, such as VCP, and regulators of membrane trafficking and cytoskeleton remodeling, such as ASAP1. These findings unveil a novel mechanism by which mutant FUS might intersect other pathogenic pathways in ALS patients' motoneurons.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Garone</LastName><ForeName>Maria Giovanna</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, P.le A. Moro 5, 00185, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Alfano</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, P.le A. Moro 5, 00185, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UMR INSERM 1052-CNRS, Cancer Research Center of Lyon (CRCL), 5286 151 cours Albert Thomas, 69424, Lyon Cedex 03, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salvatori</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Center for Life Nano Science, Istituto Italiano Di Tecnologia, Viale Regina Elena 291, 00161, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braccia</LastName><ForeName>Clarissa</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>D3 PharmaChemistry, Istituto Italiano Di Tecnologia, Via Morego 30, 16163, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peruzzi</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center for Life Nano Science, Istituto Italiano Di Tecnologia, Viale Regina Elena 291, 00161, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colantoni</LastName><ForeName>Alessio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, P.le A. Moro 5, 00185, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Life Nano Science, Istituto Italiano Di Tecnologia, Viale Regina Elena 291, 00161, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bozzoni</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, P.le A. Moro 5, 00185, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Life Nano Science, Istituto Italiano Di Tecnologia, Viale Regina Elena 291, 00161, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Armirotti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Analytical Chemistry Lab, Istituto Italiano Di Tecnologia, via Morego 30, 16163, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosa</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, P.le A. Moro 5, 00185, Rome, Italy. alessandro.rosa@uniroma1.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Life Nano Science, Istituto Italiano Di Tecnologia, Viale Regina Elena 291, 00161, Rome, Italy. alessandro.rosa@uniroma1.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, Viale Regina Elena 291, 00161, Rome, Italy. alessandro.rosa@uniroma1.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ERC-2019-SyG (855923-ASTRA)</GrantID><Acronym>ERC_</Acronym><Agency>European Research Council</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020413">3' Untranslated Regions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020543">Proteome</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020413" MajorTopicYN="Y">3' Untranslated Regions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003599" MajorTopicYN="N">Cytoskeleton</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020543" MajorTopicYN="Y">Proteome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="Y">Proteomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32678235</ArticleId><ArticleId IdType="pmc">PMC7366621</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-68794-6</ArticleId><ArticleId IdType="pii">10.1038/s41598-020-68794-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Polymenidou M, Cleveland DW. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 2010;19:R46&#x2013;64. doi: 10.1093/hmg/ddq137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq137</ArticleId><ArticleId IdType="pmc">PMC3167692</ArticleId><ArticleId IdType="pubmed">20400460</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D, et al. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 2010;29:2841&#x2013;2857. doi: 10.1038/emboj.2010.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.143</ArticleId><ArticleId IdType="pmc">PMC2924641</ArticleId><ArticleId IdType="pubmed">20606625</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang ZC, Chook YM. Structural and energetic basis of ALS-causing mutations in the atypical proline-tyrosine nuclear localization signal of the Fused in Sarcoma protein (FUS) Proc. Natl. Acad. Sci. USA. 2012;109:12017&#x2013;12021. doi: 10.1073/pnas.1207247109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1207247109</ArticleId><ArticleId IdType="pmc">PMC3409756</ArticleId><ArticleId IdType="pubmed">22778397</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D, Haass C. TDP-43 and FUS: a nuclear affair. Trends Neurosci. 2011;34:339&#x2013;348. doi: 10.1016/j.tins.2011.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2011.05.002</ArticleId><ArticleId IdType="pubmed">21700347</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakaya T, Maragkakis M. Amyotrophic lateral sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity. Sci. Rep. 2018;8:15575. doi: 10.1038/s41598-018-33964-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-33964-0</ArticleId><ArticleId IdType="pmc">PMC6197261</ArticleId><ArticleId IdType="pubmed">30349096</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron DM, et al. Quantitative proteomics identifies proteins that resist translational repression and become dysregulated in ALS-FUS. Hum. Mol. Genet. 2019;28:2143&#x2013;2160. doi: 10.1093/hmg/ddz048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz048</ArticleId><ArticleId IdType="pmc">PMC6586143</ArticleId><ArticleId IdType="pubmed">30806671</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell JC, et al. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol. 2013;125:273&#x2013;288. doi: 10.1007/s00401-012-1043-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1043-z</ArticleId><ArticleId IdType="pmc">PMC3549237</ArticleId><ArticleId IdType="pubmed">22961620</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J, Comley LH, Hedlund E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:863&#x2013;885. doi: 10.1007/s00401-017-1708-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1708-8</ArticleId><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenzi J, et al. ALS mutant FUS proteins are recruited into stress granules in induced Pluripotent Stem Cells (iPSCs) derived motoneurons. Dis. Models Mech. 2015;8:755&#x2013;766. doi: 10.1242/dmm.020099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.020099</ArticleId><ArticleId IdType="pmc">PMC4486861</ArticleId><ArticleId IdType="pubmed">26035390</ArticleId></ArticleIdList></Reference><Reference><Citation>De Santis R, et al. FUS mutant human motoneurons display altered transcriptome and microRNA pathways with implications for ALS pathogenesis. Stem Cell Rep. 2017;9:1450&#x2013;1462. doi: 10.1016/j.stemcr.2017.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.09.004</ArticleId><ArticleId IdType="pmc">PMC5830977</ArticleId><ArticleId IdType="pubmed">28988989</ArticleId></ArticleIdList></Reference><Reference><Citation>De Santis R, et al. Mutant FUS and ELAVL4 (HuD) aberrant crosstalk in amyotrophic lateral sclerosis. Cell Rep. 2019;27:3818&#x2013;3831.e5. doi: 10.1016/j.celrep.2019.05.085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.05.085</ArticleId><ArticleId IdType="pmc">PMC6613039</ArticleId><ArticleId IdType="pubmed">31242416</ArticleId></ArticleIdList></Reference><Reference><Citation>Braccia C, Tomati V, Caci E, Pedemonte N, Armirotti A. SWATH label-free proteomics for cystic fibrosis research. J. Cyst. Fibros. 2019;18:501&#x2013;506. doi: 10.1016/j.jcf.2018.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcf.2018.10.004</ArticleId><ArticleId IdType="pubmed">30348611</ArticleId></ArticleIdList></Reference><Reference><Citation>Pletscher-Frankild S, Pallej&#xe0; A, Tsafou K, Binder JX, Jensen LJ. Diseases: text mining and data integration of disease-gene associations. Methods. 2015;74:83&#x2013;89. doi: 10.1016/j.ymeth.2014.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2014.11.020</ArticleId><ArticleId IdType="pubmed">25484339</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M, et al. Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2019 doi: 10.1002/acn3.50930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.50930</ArticleId><ArticleId IdType="pmc">PMC6917314</ArticleId><ArticleId IdType="pubmed">31682085</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nch C, et al. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology. 2004;63:724&#x2013;726. doi: 10.1212/01.WNL.0000134608.83927.B1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000134608.83927.B1</ArticleId><ArticleId IdType="pubmed">15326253</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C-H, et al. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature. 2012;488:499&#x2013;503. doi: 10.1038/nature11280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11280</ArticleId><ArticleId IdType="pmc">PMC3575525</ArticleId><ArticleId IdType="pubmed">22801503</ArticleId></ArticleIdList></Reference><Reference><Citation>Pensato V, et al. TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations. J. Neurol. 2015;262:1376&#x2013;1378. doi: 10.1007/s00415-015-7739-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7739-y</ArticleId><ArticleId IdType="pmc">PMC6614739</ArticleId><ArticleId IdType="pubmed">25893256</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith BN, et al. Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis. Sci. Transl. Med. 2017;9:9157. doi: 10.1126/scitranslmed.aad9157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aad9157</ArticleId><ArticleId IdType="pmc">PMC6599403</ArticleId><ArticleId IdType="pubmed">28469040</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97:1268.e6&#x2013;1283.e6. doi: 10.1016/j.neuron.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku&#x17a;ma-Kozakiewicz M, Ka&#x17a;mierczak B, Chudy A, Gajewska B, Bara&#x144;czyk-Ku&#x17a;ma A. Alteration of motor protein expression involved in bidirectional transport in peripheral blood mononuclear cells of patients with amyotrophic lateral sclerosis. Neurodegener. Dis. 2016;16:235&#x2013;244. doi: 10.1159/000443664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000443664</ArticleId><ArticleId IdType="pubmed">26954557</ArticleId></ArticleIdList></Reference><Reference><Citation>Umoh ME, et al. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain. EMBO Mol. Med. 2018;10:48&#x2013;62. doi: 10.15252/emmm.201708202.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201708202</ArticleId><ArticleId IdType="pmc">PMC5760858</ArticleId><ArticleId IdType="pubmed">29191947</ArticleId></ArticleIdList></Reference><Reference><Citation>Randazzo PA, et al. The Arf GTPase-activating protein ASAP1 regulates the actin cytoskeleton. Proc. Natl. Acad. Sci. USA. 2000;97:4011&#x2013;4016. doi: 10.1073/pnas.070552297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.070552297</ArticleId><ArticleId IdType="pmc">PMC18133</ArticleId><ArticleId IdType="pubmed">10725410</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-P&#xe9;rez P, et al. Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis. Neurology. 2012;79:2201&#x2013;2208. doi: 10.1212/WNL.0b013e318275963b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318275963b</ArticleId><ArticleId IdType="pmc">PMC3570818</ArticleId><ArticleId IdType="pubmed">23152587</ArticleId></ArticleIdList></Reference><Reference><Citation>De Santis R, et al. Direct conversion of human pluripotent stem cells into cranial motor neurons using a piggyBac vector. Stem Cell Res. 2018;29:189&#x2013;196. doi: 10.1016/j.scr.2018.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2018.04.012</ArticleId><ArticleId IdType="pubmed">29729503</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q, et al. SWATH enables precise label-free quantification on proteome scale. Proteomics. 2015;15:1215&#x2013;1223. doi: 10.1002/pmic.201400270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.201400270</ArticleId><ArticleId IdType="pubmed">25560523</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberger G, et al. A repository of assays to quantify 10,000 human proteins by SWATH-MS. Sci. Data. 2014;1:140031. doi: 10.1038/sdata.2014.31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2014.31</ArticleId><ArticleId IdType="pmc">PMC4322573</ArticleId><ArticleId IdType="pubmed">25977788</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku&#x17a;ma-Kozakiewicz M, et al. Dynactin Deficiency in the CNS of Humans with Sporadic ALS and Mice with Genetically Determined Motor Neuron Degeneration. Neurochem. Res. 2013 doi: 10.1007/s11064-013-1160-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-013-1160-7</ArticleId><ArticleId IdType="pmc">PMC3898179</ArticleId><ArticleId IdType="pubmed">24078265</ArticleId></ArticleIdList></Reference><Reference><Citation>Patzke H, Tsai L-H. Cdk5 sinks into ALS. Trends Neurosci. 2002;25:8&#x2013;10. doi: 10.1016/S0166-2236(00)02000-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-2236(00)02000-2</ArticleId><ArticleId IdType="pubmed">11801324</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado L, et al. A novel peripherin gene (PRPH) mutation identified in one sporadic amyotrophic lateral sclerosis patient. Neurobiol. Aging. 2011;32(552):e1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20363051</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, et al. Mitochondrial fusion and fission proteins expression dynamically change in a murine model of amyotrophic lateral sclerosis. Curr. Neurovasc. Res. 2013;10:222&#x2013;230. doi: 10.2174/15672026113109990060.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/15672026113109990060</ArticleId><ArticleId IdType="pubmed">23713734</ArticleId></ArticleIdList></Reference><Reference><Citation>Taskesen E, et al. Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS. Sci. Rep. 2017;7:8899. doi: 10.1038/s41598-017-09320-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09320-z</ArticleId><ArticleId IdType="pmc">PMC5567187</ArticleId><ArticleId IdType="pubmed">28827549</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Andrea D, Grassi L, Mazzapioda M, Tramontano A. FIDEA: a server for the functional interpretation of differential expression analysis. Nucleic Acids Res. 2013;41:W84&#x2013;W88. doi: 10.1093/nar/gkt516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt516</ArticleId><ArticleId IdType="pmc">PMC3692084</ArticleId><ArticleId IdType="pubmed">23754850</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>